Treatment with rapamycin prevents fibrosis in tight‐skin and bleomycin‐induced mouse models of systemic sclerosis
Ayumi Yoshizaki(University of Tokyo Hospital), Shinichi Sato(University of Tokyo Hospital), Kazuhiro Komura(Kanazawa University), Yoshihide Asano(Tohoku University), Asako Yoshizaki(Nagasaki University), Kazuhiro Shimizu(Toho University), Koichi Yanaba(Jikei University School of Medicine), Minoru Hasegawa(University of Fukui), Yohei Iwata(Fujita Health University), Motoi Takenaka(Washington University in St. Louis), Fumihide Ogawa(Nagasaki University), Manabu Fujimoto(Osaka Gakuin University)
Cited by 126
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals
|The Journal of Immunology|2009|489
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438